658
R. Breslow et al. / Tetrahedron 58 (2002) 653±659
(SiO2) with CHCl3/CH3OH (10:1) as eluent. 1H NMR
(CDCl3, 300 MHz) d: 8.93±8.81 (m, 7H), 8.62 (m, 2H),
8.06 (d, 1H, J7.5 Hz), 7.85 (m, 2H), 7.65 (m, 2H), 6.69
(m, 2H), 6.46 (m, 1H), 2.25 (t, 2H, J7.4 Hz), 1.56 (t, 2H,
J7.4 Hz), 22.89 (s, 2H). FAB-MS: 1033.3 [M1H]1. UV±
vis (CH2Cl2): 414 (Soret), 508, 579 nm.
catalyst, the conversion to the single product 4 was
quantitative.
Substrate 3 (0.06 mmol) was dissolved in 60 ml water and
the pH was adjusted to 5.5. To this solution, 0.00020 equiv.
catalyst 6 or 7 in water was added by syringe. The solution
was stirred at room temperature in the dark for 10 min. A
solution of iodosylbenzene (66 mg, 0.30 mmol) in 3.0 ml
methanol was added in several aliquots over 4 h. The
mixture was stirred for 6 h at room temperature. After the
excess oxidant was quenched, with sodium thiosulfate 25%
aqueous KOH (20 ml) was added and the mixture was stir-
red overnight. The solution was extracted with EtOAc
(4£50 ml). The organic layer was washed with saturated
brine and dried over Na2SO4. Evaporation of the solvent
and column chromatography (SiO2) gave the product 4
and recovered starting material.
Then, porphyrin 6 was obtained from this porphyrin in 72%
yield by reacting it (190 mg, 0.184 mmol) with 6-deoxy-6-
mercapto-b-cyclodextrin (847 mg, 0.736 mmol) using the
same procedure as described above for 7.
1H NMR (DMSO-d6, 300 MHz) d: 9.26±8.87 (m, 9H), 8.15
(d, 1H, J6.73 Hz), 8.08 (d, 1H, J8.19 Hz), 7.99 (d, 1H,
J4.6 Hz), 7.90±7.85 (m, 2H), 7.65 (t, 1H), 6.85 (d, 1H,
J7.50 Hz), 6.72 (m, 1H), 5.86±5.68 (m, 42H, 28-OH),
5.03±4.32 (m, 39H, H1, 18-OH), 3.66±3.32 (m, 126H),
2.11 (t, 2H, J8.06 Hz), 1.70 (t, 2H, J8.06 Hz), 23.03
(s, 2H). MALDI MS: 4452.68 [M1Na]1 UV±vis (H2O):
413 (Soret), 509, 580 nm.
With catalyst 7, the oxidation conversion was 65.4%, turn-
overs were 2900. With catalyst 6, the oxidation conversion
is 50.1%, turnovers are 2200. In the earlier work with
catalyst 5-Mn(III), the turnovers were also determined by
benzoylating the mixture of product and starting polyols,
and assaying them by HPLC and by gas chromatography.
4.2. Substrates
Substrate 3 was prepared as described and fully character-
ized previously.14,15 The procedure and characterization are
parallel to that used for substrate 8, described below.
4.4. Product identi®cation
Product 4 was identi®ed originally from its NMR spectrum,
but was then compared with an authentic sample obtained
from Steraloids Inc., as reported earlier.14,15 Product 10 had
1H NMR (CDCl3, 500 MHz): d: 3.73 (t, 1H, C17-H), 3.58
(m, 1H, C3-H), 3.43 (dt, 1H, C6-H), 0.959 (s, 3H, C19-Me),
0.753 (s, 3H, C18-Me). CI-MS: m/z342 (M111NH3),
323 (M21, neg.). The chemical shifts of the angular methyl
groups were consistent with reported values for 9-hydroxyl-
ation.26 NOESY indicated that the C5 and C7a protons
moved down®eld signi®cantly relative to starting triol 4,
as expected for their 1,3-diaxial relation to the 9-OH.
Product 11 had an additional low-®eld C±H relative to 4,
at d: 4.16. The COSY spectrum showed that is was coupled
to the C-16 protons, which were also coupled to the C-17
proton. The chemical shifts for the C-18-Me at 0.98
(predicted 1.00) and the C-19-Me at 0.88 (predicted 0.89)
were as expected for a 15-bOH group.26
Substrate 8 was prepared by reaction of 136 mg of triol 4,
prepared by our catalytic hydroxylation of 3, with 650 mg of
3(4-tert-butylphenyl)glutaric anhydride in 100 ml methyl-
ene chloride with 460 ml of DBU for 12 h at 238C. The
solution was washed with aqueous ammonium chloride
and dried with sodium sulfate, then directly treated with
608 mg of N-hydroxysuccinimide and 1.0 g of EDC. The
triactivated triester product was isolated by column chroma-
tography in 55% yield, and had 1H NMR (500 MHz,
CDCl3): d: 7.29 (m, 6H, aromatic), 7.15 (m, 6H, aromatic),
4.51±4.39 (m, 3H, C3-H1C6-H1C17-H), 3.65 (m, 3H,
benzylic C-H's), 2.80 (s, 12H, succinimide-H's), 1.28 (s,
27H, tert-butyl), 0.76 (m, 3H, C19-Me from different
diastereomers), 0.56 (m, 3H, C18-Me from different dia-
stereomers), 3.01±2.67 (12H, linker-H's), 2.0±0.51 (23H,
steroid envelope). FAB-MS: m/z1336 (M11).
The triester was then treated with 6 equiv. of taurine and
6 equiv. of triethylamine in 20 ml anhydrous DMF over-
night, the solvent was removed and the product 8 was
Acknowledgements
1
isolated as a precipitate from 10 ml of 2N HCl. H NMR
(500 MHz, d6-DMSO): d: 7.68 (m, 3H, amide-H's), 7.22
(m, 6H, aromatic), 7.07 (m, 6H, aromatic), 4.25 (m, 3H,
C3-H1C6-H1C17-H), 3.20 (m, 6H, taurine-H's adjacent
to the nitrogen), 0.62 (s, 3H, C19-Me), 0.46 (s, 3H, C18-
Me), 3.4±2.28 (21H, linker-H's), 1.85±0.30 (23H, steroid
envelope).
We thank some of the previous collaborators on this overall
project, listed in the references, and acknowledge support of
this work by the NIH, the NSF, and the EPA. Jerry Yang
acknowledges support by an NCERQA STAR graduate
fellowship and Bristol-Myers Squibb graduate fellowship.
4.3. Hydroxylations
References
The procedures are described for the oxidation of substrate 3
by catalysts 6-Mn(III) and 7-Mn(III). The procedures are
similar for catalyst 5-Mn(III). The procedures described are
those that gave incomplete conversion, so the turnover by
the catalyst could be determined. With higher amounts of
1. Barton, D. H. R.; Beaton, J. M. J. Am. Chem. Soc. 1961, 83,
750.
2. Meunier, B. Chem. Rev. 1992, 92, 1411.
3. Breslow, R. Chem. Soc. Rev. 1972, 1, 553.
4. Breslow, R. Acc. Chem. Res. 1980, 13, 170.